During the third quarter, GDS Wealth Management reduced its position in UnitedHealth Group by 10.7%, selling 5,297 shares and ending the period with 44,252 shares valued at $15.28 million. In the same period, Cullen Frost Bankers Inc. trimmed its holdings by 27.1%, disposing of 29,527 shares and retaining 79,459 shares worth $27.44 million. Other managers, including LFA Lugano Financial Advisors and Sagard Holdings Management, initiated small positions valued between $25,000 and $33,000, while Riggs Asset Management increased its stake by 69.4% to 105 shares on a $33,000 basis. Hedge funds and institutional investors collectively own 87.86% of the company’s shares.

In October, Jefferies Financial Group raised its target from $317 to $409 and maintained a Buy rating. Goldman Sachs initiated coverage with a Buy rating and a $406 objective. UBS lifted its target from $378 to $430 and kept a Buy stance, while Piper Sandler moved its objective from $423 to $417 with an Overweight rating. Mizuho boosted its target from $300 to $430 and affirmed an Outperform rating. Among 29 analysts covering the stock, one rates it Strong Buy, seventeen Buy, nine Hold and two Sell, yielding a consensus Moderate Buy recommendation and an average target of $386.33.

In its third–quarter announcement, UnitedHealth reported earnings per share of $2.92, exceeding the consensus by $0.05, and delivered revenue of $113.16 billion, matching estimates within a narrow margin. Revenues climbed 12.2% year-over-year, net margin stood at 4.04% and return on equity reached 19.23%. The company’s trailing P/E ratio is 18.60, PEG ratio is 2.15, and it carries a debt-to-equity ratio of 0.71. Market capitalization is approximately $323 billion, and institutional ownership remains near 88%.

UnitedHealth Group paid a quarterly dividend of $2.21 per share on December 16, reflecting an annualized payout of $8.84 and a yield of 2.5%. The ex-dividend date was December 8, with record date December 8. The current dividend payout ratio is 46.14%, supported by normalized free cash flow trends and consistent segment-level margin contributions across UnitedHealthcare and Optum platforms.